196 related articles for article (PubMed ID: 25642751)
1. The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).
Peisah C; Strukovski JA; Wijeratne C; Mulholland R; Luscombe G; Brodaty H
Int Psychogeriatr; 2015 Aug; 27(8):1313-22. PubMed ID: 25642751
[TBL] [Abstract][Full Text] [Related]
2. Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK.
Bishara D; Taylor D; Howard RJ; Abdel-Tawab R
Int J Geriatr Psychiatry; 2009 Sep; 24(9):944-54. PubMed ID: 19156700
[TBL] [Abstract][Full Text] [Related]
3. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.
Haw C; Stubbs J; Yorston G
Int Psychogeriatr; 2008 Aug; 20(4):790-9. PubMed ID: 18307825
[TBL] [Abstract][Full Text] [Related]
5. Rationalising Antipsychotic Prescribing in Dementia (RAPID) complex intervention: A mixed-methods feasibility intervention study.
Walsh KA; Byrne S; O'Riordan A; McSharry J; Browne J; Irving K; Hurley E; Timmons S
Explor Res Clin Soc Pharm; 2022 Dec; 8():100190. PubMed ID: 36277309
[TBL] [Abstract][Full Text] [Related]
6. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
Pinheiro D
Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
[TBL] [Abstract][Full Text] [Related]
7. Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project.
Harrison F; Cations M; Jessop T; Aerts L; Chenoweth L; Shell A; Sachdev P; Hilmer S; Draper B; Brodaty H
Int Psychogeriatr; 2020 Mar; 32(3):335-345. PubMed ID: 31969207
[TBL] [Abstract][Full Text] [Related]
8. A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol.
Hølmkjær P; Holm A; Overbeck G; Rozing MP
Trials; 2022 May; 23(1):410. PubMed ID: 35578351
[TBL] [Abstract][Full Text] [Related]
9. Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.
Jessop T; Harrison F; Cations M; Draper B; Chenoweth L; Hilmer S; Westbury J; Low LF; Heffernan M; Sachdev P; Close J; Blennerhassett J; Marinkovich M; Shell A; Brodaty H
Int Psychogeriatr; 2017 Aug; 29(8):1391-1403. PubMed ID: 28266282
[TBL] [Abstract][Full Text] [Related]
10. A new simple score (ABS) for assessing behavioral and psychological symptoms of dementia.
Abe K; Yamashita T; Hishikawa N; Ohta Y; Deguchi K; Sato K; Matsuzono K; Nakano Y; Ikeda Y; Wakutani Y; Takao Y
J Neurol Sci; 2015 Mar; 350(1-2):14-7. PubMed ID: 25662676
[TBL] [Abstract][Full Text] [Related]
11. Development of a Thai tool for assessing behavioral and psychological symptoms of dementia: A confirmatory factor analysis.
Phannarus H; Muangpaisan W; Siritipakorn P; Pianchob S; Supapueng O
Brain Behav; 2020 Nov; 10(11):e01816. PubMed ID: 32857486
[TBL] [Abstract][Full Text] [Related]
12. Primary Care Physician Perspectives about Antipsychotics and Other Medications for Symptoms of Dementia.
Kerns JW; Winter JD; Winter KM; Boyd T; Etz RS
J Am Board Fam Med; 2018; 31(1):9-21. PubMed ID: 29330235
[TBL] [Abstract][Full Text] [Related]
13. [The Adaptation of Anti-dementia Drugs for BPSD].
Hashimoto M
Seishin Shinkeigaku Zasshi; 2016; 118(6):436-442. PubMed ID: 30620504
[TBL] [Abstract][Full Text] [Related]
14. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
Matsunaga S; Kishi T; Iwata N
J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
Desmidt T; Hommet C; Camus V
Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
[TBL] [Abstract][Full Text] [Related]
16. Development of a tool for monitoring the prescribing of antipsychotic medications to people with dementia in general practice: a modified eDelphi consensus study.
Jennings AA; Guerin N; Foley T
Clin Interv Aging; 2018; 13():2107-2117. PubMed ID: 30425465
[TBL] [Abstract][Full Text] [Related]
17. [Improving the quality of care for people with behavioral and psychological symptoms of dementia in Quebec].
Bruneau MA; Pépin MÉ; Bergman H; Couturier Y
Sante Ment Que; 2023; 48(2):229-255. PubMed ID: 38578191
[TBL] [Abstract][Full Text] [Related]
18. Caregiver Perspectives About Using Antipsychotics and Other Medications for Symptoms of Dementia.
Kerns JW; Winter JD; Winter KM; Kerns CC; Etz RS
Gerontologist; 2018 Mar; 58(2):e35-e45. PubMed ID: 28402533
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Rösler M
Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
[TBL] [Abstract][Full Text] [Related]
20. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
Kim JM; Lyons D; Shin IS; Yoon JS
Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
